Intersect Ent Inc XENT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/18/21 EDT
16.34UNCH (UNCH)
Volume
8,763
Close
16.34quote price arrow down-0.39 (-2.33%)
Volume
154,818
52 week range
11.66 - 26.98

...

Loading . . .
  • Open16.39
  • Day High16.90
  • Day Low16.11
  • Prev Close16.73
  • 52 Week High26.98
  • 52 Week High Date01/25/21
  • 52 Week Low11.66
  • 52 Week Low Date06/26/20

Key Stats

  • Market Cap541.51M
  • Shares Out33.14M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.63
  • YTD % Change-28.65

KEY STATS

  • Open16.39
  • Day High16.90
  • Day Low16.11
  • Prev Close16.73
  • 52 Week High26.98
  • 52 Week High Date01/25/21
  • 52 Week Low11.66
  • 52 Week Low Date06/26/20
  • Market Cap541.51M
  • Shares Out33.14M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.63
  • YTD % Change-28.65

RATIOS/PROFITABILITY

  • EPS (TTM)-2.28
  • P/E (TTM)-7.16
  • Fwd P/E (NTM)-10.74
  • EBITDA (MRQ)-61.462M
  • ROE (MRQ)-93.45%
  • Revenue (MRQ)85.06M
  • Gross Margin (MRQ)61.97%
  • Net Margin (MRQ)-87.96%
  • Debt To Equity (MRQ)122.88%

EVENTS

  • Earnings Date08/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Intersect Ent Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology is designed to allow ENT physicians to manage patient care. The Company's commercial products are the PROPEL and PROPEL mini drug-releasing implants...
Kieran Gallahue
Non-Executive Chairman
Thomas West
President
Richard Meier
Chief Financial Officer
Patrick Broderick
Executive Vice President
Mark Alley
Vice President
Address
1555 Adams Dr
Menlo Park, CA
94025-1439
United States

Top Peers

SYMBOLLASTCHG%CHG
ZYXI
Zynex Inc
15.82+0.54+3.53%
SIEN
Sientra Inc
7.54-0.20-2.58%
INFU
InfuSystem Holdings Inc
18.92-0.34-1.77%
MSON
Misonix Inc
22.30-1.28-5.43%
VAPO
Vapotherm Inc
23.56-0.21-0.88%